Increased expression of the mRNA encoding the somatostatin receptor subtype five in human colorectal adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Molecular Endocrinology

• Publication date

  2000-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JME.0.0240397PMID 10828833
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practical Program Evaluation: Assessing and Improving Planning, Implementation, and Effectiveness

  2005cited by this paper
• Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).

  1999cited by this paper
• No loss of sst receptors gene expression in advanced stages of colorectal cancer.

  1999cited by this paper
• C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest.

  1999influential reference
• Role of nitric oxide in the antiproliferative signal mediated by the somatostatin receptor sst5

  1998cited by this paper
• Inhibitory effect of somatostatin on human T lymphocytes proliferation.

  1998cited by this paper
• An In Situ Hybridization Histochemistry Technique Allowing Simultaneous Visualization by the Use of Confocal Microscopy of Three Cellular mRNA Species in Individual Neurons

  1998cited by this paper
• Expression of somatostatin receptor subtypes in human brain tumors

  1998cited by this paper
• Mechanisms of Antineoplastic Action of Somatostatin Analogs

  1998cited by this paper
• The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines.

  1997cited by this paper
• Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.

  1997influential reference
• Molecular pharmacology of somatostatin receptor subtypes

  1997cited by this paper
• Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

  1997cited by this paper
• Somatostatin receptors.

  1997influential reference
• Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract.

  1997cited by this paper
• Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae.

  1997influential reference
• Inhibition of tumor cell kinetics and serum insulin growth factor I levels by octreotide in colorectal cancer patients.

  1997cited by this paper
• Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.

  1996influential reference
• Somatostatin receptors and disease: role of receptor subtypes.

  1996cited by this paper
• Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon.

  1996cited by this paper
• Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture.

  1996cited by this paper
• A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

  1996cited by this paper
• Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.

  1996cited by this paper
• Local up-regulation of neuropeptide receptors in host blood vessels around human colorectal cancers.

  1996cited by this paper
• Expression of five somatostatin receptor mRNAs in the human brain and pituitary

  1996cited by this paper
• Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors.

  1996cited by this paper
• In-vivo effect of somatostatin analog, lanreotide, and/or grp antagonist, bim-26226, on the growth of colon-cancer peritoneal carcinomatosis in the rat.

  1995cited by this paper
• Expression of multiple somatostatin receptor genes in human colonic epithelial cells.

  1995cited by this paper
• Octreotide reduces the kinetic index, proliferating cell nuclear antigen–maximum proliferative index, in patients with colorectal cancer

  1995cited by this paper
• Octreotide inhibits the growth and development of three types of experimental liver metastases

  1995influential reference
• Molecular Pharmacology of Somatostatin‐receptor Subtypes

  1994cited by this paper
• High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor‐host interaction?

  1994cited by this paper
• Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

  1994cited by this paper
• Somatostatin and the immune and haematopoetic system; a review

  1994cited by this paper
• Somatostatin binding in human gastrointestinal tissues: effect of cations and somatostatin analogues.

  1993influential reference
• Neostigmine stimulates growth hormone-releasing hormone release into hypophysial portal blood of conscious sheep.

  1993cited by this paper
• Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats.

  1993cited by this paper
• Somatostatin inhibits both in-vitro and in-vivo carcinoembryonic antigen secretion by human colon cancer.

  1993cited by this paper
• G Protein Activation of a Hormone-Stimulated Phosphatase in Human Tumor Cells

  1992cited by this paper
• Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue.

  1992cited by this paper
• Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC‐160

  1992cited by this paper
• The Binding of Bombesin and Somatostatin and Their Analogs to Human Colon Cancers

  1992cited by this paper
• Somatostatin receptors in human colorectal cancer.

  1992cited by this paper
• The somatostatin receptor in the GI tract.

  1992cited by this paper
• SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer.

  1992cited by this paper
• The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

  1991cited by this paper
• The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer.

  1991cited by this paper
• Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activation.

  1991cited by this paper
• Somatostatin analogue rc‐160 inhibits the growth of transplanted colon cancer in rats

  1991cited by this paper
• Enhancement of human lymphocyte natural killer activity by somatostatin.

  1989cited by this paper
• Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer.

  1988cited by this paper
• Immunomodulatory Action of Somatostatin

  1987cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

  1978cited by this paper
• The Spread of Rectal Cancer and its Effect on Prognosis

  1958cited by this paper

• Differentially Expressed Somatostatin (SST) and Its Receptors (SST1-5) in Sporadic Colorectal Cancer and Normal Colorectal Mucosa

  2024influential citation
• Somatostatin and Its Receptor System in Colorectal Cancer

  2021cites this paper
• Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm

  2013cites this paper
• The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review.

  2009cites this paper
• Somatostatin inhibits colon cancer cell growth through cyclooxygenase‐2 downregulation

  2008cites this paper
• Diagnostic targeting of colon cancer using a novel fluorescent somatostatin conjugate in a mouse xenograft model

  2008influential citation
• Somatostatin Analogs in Diagnostics and Therapy

  2007cites this paper
• Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.

  2006cites this paper
• [The incidence of somatostatin receptors in human neoplasms in the light of ex vivo-in vitro studies].

  2006cites this paper
• CHAPTER 154 – Somatostatin

  2006cites this paper
• Prognostic value of somatostatin receptor subtype 2 expression in colorectal cancer.

  2005cites this paper
• Cellular detection of sst2A receptors in human gastrointestinal tissue

  2004cites this paper
• Somatostatin receptors and their interest in diagnostic pathology

  2004cites this paper
• Somatostatin receptors in non-endocrine tumours.

  2004cites this paper
• Perspectives of new potential therapeutic applications of somatostatin analogs.

  2003cites this paper
• Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa.

  2002cites this paper
• Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status.

  2002cites this paper
• Molecular cloning and tissue distribution of the ovine somatostatin receptor subtype 5: osst5.

  2002cites this paper
• Independently of Their p 53 Status Somatostatin Receptor-positive Experimental Colon Cancers Targeted Cytotoxic Somatostatin Analogue AN-238 Inhibits Updated

  2002cites this paper
• [Somatostatin receptors in non-endocrine tumours].

  2001cites this paper